Valeritas Holdings, Inc. – Creditors’ Committee Objects to Onerous DIP Financing Terms, Suggests that Developments as to Debtors’ Insulin Products May be Financing and Asset Sale Game-Changer

March 5, 2020 – The Debtors' Official Committee of Unsecured Creditors (the “Committee”) objected to the Debtors’ proposed debtor-in-possession (“DIP”) financing motion arguing, inter alia, that milestones in respect of the Debtors' intended sale to Zealand Pharma A/S (NASDAQ: ZEAL; "Zealand') are too aggressive, interest (18%) is too high, fees are excessive and that avoidance…